NUS ACRLE

About

This symposium is a testament to the commitment of NUS Bia Echo Asia Centre for Reproductive Longevity and Equality (ACRLE) and CHA University Global IVF Group to advancing the science of Reproductive Medicine and to spearhead efforts in the research of human fertility to improve reproductive outcomes. The theme of this inaugural symposium is, ” Advances in Reproductive Medicine in Asia-Pacific” where experts in the field of Reproductive Medicine convene, present, and discuss the latest innovations and developments in assisted reproductive treatments and IVF technologies. This symposium is highly relevant to practitioners in Reproductive Medicine, clinical embryologists, Reproductive scientists and academics dedicated to this field.

Our Speakers

coming soon

Programme

coming soon

About NUS Bia-Echo Asia Centre for Reproductive Longevity and Equality (ACRLE)

The work of the Centre is focused within four strategic tracks. The effort within the tracks will seek to find ways to improve and lengthen female reproductive health and longevity, help women to preserve and improve their reproductive systems for conception and general health, potentially enable women to conceive safely in their later years, and to remain healthy longer. ACRLE advocates and educates on reproductive equality for all and works closely with other academic institutions and stakeholders to change the narrative of reproductive longevity and equality.

About CHA University Global IVF Group

CHA Medical Group’s CHA Fertility Centers, with the Gangnam CHA Medical Center as its base, are located in various places both domestically (CHA Fertility Center Seoul Station, Bundang CHA Women’s Hospital, Gumi CHA Medical Center, Daegu CHA Women’s Hospital, etc.) and internationally (LA CHA Hollywood Presbyterian Medical Center etc.), making up a broad global network.

CHA Fertility Center is a leader within the Pacific Society for Reproductive Medicine, one of the world’s top three medical academic organizations in reproductive medicine. CHA has established itself as a pioneer in the field of reproductive medicine through innovative ideas and research, and development has continued to strengthen its status as premier global health care group.